Vivos Therapeutics Inc【VVOS】 業績推移・財務諸表

(単位:千ドル) 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25
現金同等物 18,205 14,058 34,198 28,534 24,000 17,800 12,700 6,700 3,500 7,000 3,900 1,000 1,600 2,600 6,900 6,300 6,300 2,300
現金 + 有価証券 18,205 14,058 34,198 28,534 24,000 17,800 12,700 6,700 3,500 7,000 3,900 1,000 1,600 2,600 6,900 6,300 6,300 2,300
売掛金 1,430 1,664 3,460 3,833 1,203 1,002 791 866 457 321 327 228 202 525 395 454 430 718
流動資産合計 20,394 16,735 39,388 34,031 27,324 21,601 15,513 9,701 5,424 8,713 5,342 1,985 2,461 3,611 7,852 7,399 7,473 3,607
有形固定資産 871 1,058 2,291 2,601 2,825 2,913 3,109 3,044 3,082 3,157 3,267 3,283 3,314 3,332 3,259 3,317 3,350 3,308
固定資産合計 4,933 5,218 6,767 6,992 6,365 7,955 8,862 8,699 8,296 8,387 8,407 8,332 8,269 8,193 7,990 7,948 7,811 7,675
総資産 25,327 21,953 46,156 41,024 33,689 29,556 24,375 18,400 13,720 17,100 13,749 10,317 10,730 11,804 15,842 15,347 15,284 11,282
買掛金 781 869 1,298 700 920 877 1,252 644 1,411 1,495 1,325 1,528 2,145 2,499 2,028 1,075 1,098 1,206
一年内返済予定の長期借入金 866 1,159 1,265 1,265 1,265 - - - - - - - - - - - - -
流動負債合計 7,823 7,295 9,314 8,195 7,509 6,851 6,694 5,964 6,813 7,975 8,440 7,167 7,289 8,070 6,643 5,126 4,978 4,701
長期借入金 423 105 - - - - - - - - - - - - - - - -
固定負債合計 587 317 358 360 591 1,849 2,806 2,536 2,087 2,125 3,160 3,133 3,011 3,130 2,857 2,574 2,322 2,199
総負債 8,410 7,613 9,672 8,555 8,100 8,700 9,500 8,500 8,900 10,100 11,600 10,300 10,300 11,200 9,500 7,700 7,300 6,900
資本金及び資本剰余金 52,252 53,074 79,260 80,698 81,162 81,993 82,785 83,235 84,271 88,164 88,805 88,838 93,462 97,396 105,091 109,025 112,141 112,458
利益剰余金 -35,335 -38,734 -42,777 -48,230 -55,600 -61,100 -67,900 -73,400 -79,468 -81,200 -86,700 -88,800 -93,051 -96,800 -98,700 -101,400 -104,200 -108,100
株主資本 16,917 14,340 36,483 32,469 25,539 20,855 - 9,855 4,801 6,993 2,106 46 411 582 6,347 7,665 7,954 4,407
有利子負債合計 1,290 1,265 1,265 1,265 1,265 - - - - - - - - - - - - -
純有利子負債 -16,916 -12,793 -32,934 -27,270 -22,735 - - - - - - - - - - - - -
DEレシオ(%) 7.63 8.82 3.47 3.9 4.95 - - - - - - - - - - - - -